Search

Author/Creator Rayner, Craig R.

2. Evaluation of the Cardiac Safety of Long‐Acting Endectocide Moxidectin in a Randomized Concentration‐QT Study. Issue 6 (19th September 2018)

Authors:
Kinrade, Sally A.; Mason, Jay W.; Sanabria, Carlos R.; Rayner, Craig R.; Bullock, Julie M.; Stanworth, Stephanie H.; Sullivan, Mark T.
Journal:
Clinical and translational science
Issue:
Volume 11:Issue 6(2018)
Page Start:
582
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Using in silico viral kinetic models to guide therapeutic strategies during a pandemic: An example in SARS‐CoV‐2. Issue 9 (15th January 2021)

Authors:
Patel, Kashyap; Dodds, Michael; Gonçalves, Antonio; Kamal, Mohamed A.; Rayner, Craig R.; Kirkpatrick, Carl M.; Smith, Patrick F.
Journal:
British journal of clinical pharmacology
Issue:
Volume 87:Issue 9(2021)
Page Start:
3425
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Model‐informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospection. Issue 9 (23rd February 2021)

Authors:
Dodds, Michael; Xiong, Yuan; Mouksassi, Samer; Kirkpatrick, Carl M.; Hui, Katrina; Doyle, Eileen; Patel, Kashyap; Cox, Eugène; Wesche, David; Brown, Fran; Rayner, Craig R.
Journal:
British journal of clinical pharmacology
Issue:
Volume 87:Issue 9(2021)
Page Start:
3388
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future. Issue 4 (9th March 2021)

Authors:
Rayner, Craig R.; Smith, Patrick F.; Andes, David; Andrews, Kayla; Derendorf, Hartmut; Friberg, Lena E.; Hanna, Debra; Lepak, Alex; Mills, Edward; Polasek, Thomas M.; Roberts, Jason A.; Schuck, Virna; Shelton, Mark J.; Wesche, David; Rowland‐Yeo, Karen
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 109:Issue 4(2021)
Page Start:
867
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment. Issue 5 (2nd July 2015)

Authors:
Kamal, Mohamed A.; Brennan, Barbara J.; Subramoney, Vishak; Lien, Yi Ting (Kayla); Morcos, Peter N.; Frey, Nicolas; Rayner, Craig R.
Journal:
Clinical pharmacology in drug development
Issue:
Volume 4:Issue 5(2015:Sep./Oct.)
Page Start:
326
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Pharmacokinetics and safety of oseltamivir in patients with end‐stage renal disease treated with automated peritoneal dialysis. (April 2015)

Authors:
Patel, Kashyap; Rayner, Craig R.; Giraudon, Mylène; Kamal, Mohamed A.; Morcos, Peter N.; Robson, Richard; Kirkpatrick, Carl M.
Journal:
British journal of clinical pharmacology
Issue:
Volume 79:Number 4(2015:Apr.)
Page Start:
624
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics. (20th February 2017)

Authors:
Kamal, Mohamed A.; Smith, Patrick F.; Chaiyakunapruk, Nathorn; Wu, David B. C.; Pratoomsoot, Chayanin; Lee, Kenneth K. C.; Chong, Huey Yi; Nelson, Richard E.; Nieforth, Keith; Dall, Georgina; Toovey, Stephen; Kong, David C. M.; Kamauu, Aaron; Kirkpatrick, Carl M.; Rayner, Craig R.
Journal:
British journal of clinical pharmacology
Issue:
Volume 83:Number 7(2017)
Page Start:
1580
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗